Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Dec 21, 2020 2:55pm
151 Views
Post# 32154269

QuestCap to Host Investor Webinar December 23 at 1 pm EST

QuestCap to Host Investor Webinar December 23 at 1 pm ESTQuestCap to Host Investor Webinar to Provide Update On Growth of Collection Sites’ COVID-19 Testing Network


TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- QuestCap Inc. (“QuestCap”) (NEO:QSC; OTC:COPRF; FRA:34C1) is pleased to announce it is hosting a Corporate Update webinar, Wednesday December 23rd at 1 pm ET that will provide investors with an update on the Company's business developments, with a primary focus on the Collection Sites subsidiary.

Registration Link: https://us02web.zoom.us/webinar/register/WN_IzooBtdgRL24-7eU00n86w

Specifically, QuestCap CEO Doug Sommerville and Collection Sites, LLC President Tim Shelburn will discuss the growth of Collection Sites’ COVID-19 testing network.

Recent Performance Highlights Include:

  • 31 sites now operational, showing strong test sales with 7-day rolling average of 82 tests per day per site and average test price of $85 per test;
  • On a 30-day run-rate basis, the 31 sites are generating US$6 million based on a 7-day rolling average;
  • Average sales expected to increase as new sites become listed on google and awareness grows;
  • On track to have Phase 1 sites (25 sites additional to original 20 launched in November) operational before Christmas;
  • Phase 2 planning continues with another 50-70 collection sites to be placed by year end, with some expected to be operational before year-end. Phase 2 sites will over double Collection Sites current network and potential sales revenue once fully operational.

About Collection Sites

Collection Sites COVID-19 testing centers offer convenient access to rapid antibody and antigen tests - which take 8-10 minutes to administer and provide results in less than 24 hours. The sites also offer regular RT-PCR, with results within 24 hours of testing. The testing centres are powered by Alcala Testing and Analysis Services, a CLIA-licensed laboratory based in San Diego, California. All tests can be administered with insurance coverage options. The tests results can be communicated via text or email and can be accompanied with a certificate of good health via a HIPAA-compliant smartphone application.

https://www.globenewswire.com/news-release/2020/12/21/2148966/0/en/QuestCap-to-Host-Investor-Webinar-to-Provide-Update-On-Growth-of-Collection-Sites-COVID-19-Testing-Network.html 

For more information about the pop-up lab, the available sites and services visit www.testbeforeyougo.com.

<< Previous
Bullboard Posts
Next >>